The average P/S ratio for ZBH's competitors is 4.14, providing a benchmark for relative valuation. Zimmer Biomet Holdings Inc Corp (ZBH) exhibits a P/S ratio of 2.20, which is -46.75% above the industry average. Given its robust revenue growth of 1.05%, this premium appears unsustainable.